Extend your brand profile by curating daily news.

Visory Health Ranks Among Top U.S. Prescription Card Platforms, Addressing Medication Affordability Crisis

By FisherVista

TL;DR

Visory Health's top-three prescription discount platform status offers significant savings up to 80% at major pharmacies, providing a financial advantage for managing healthcare costs.

Visory Health's platform uses proprietary technology with price search and pharmacy finder tools to deliver consistent savings at over 37,000 pharmacies nationwide.

Visory Health makes medications affordable for underserved communities and pharmacy deserts, creating healthier families and breaking down healthcare access barriers.

Visory Health's free prescription discount card saves up to 80% on medications and has earned multiple awards for its innovative healthcare accessibility work.

Found this article helpful?

Share it with your network and spread the knowledge!

Visory Health Ranks Among Top U.S. Prescription Card Platforms, Addressing Medication Affordability Crisis

Visory Health has achieved recognition as one of the top three prescription discount card platforms in the United States, according to data from IQVIA, marking its fourth anniversary. This development is significant as it highlights a growing solution for the millions of Americans facing financial hardship due to escalating prescription medication prices. The platform's rise to prominence underscores a critical need in the healthcare landscape for accessible and affordable medication options.

The company's free digital prescription discount card enables consumers to save up to 80% on thousands of medications at more than 37,000 pharmacies nationwide, including major chains such as Kroger, Publix, Walgreens, Albertsons, and Smith's. This extensive network is particularly impactful for individuals living in pharmacy deserts, where access to pharmacies is limited. The Visory Health website and mobile app integrate price search and pharmacy finder tools, simplifying the process for users to locate savings. For more details on their services, visit https://www.visoryhealth.com.

Susan Lang, CEO of Visory Health, emphasized the company's community-focused mission. "It's critical that patients can fill their prescriptions at a cost that doesn't damage their family budget," Lang stated. The platform's proprietary technology is designed to deliver consistent savings, which has been transformative in reducing out-of-pocket costs for patients. Alexandra Robertson, Senior Vice President of Growth at Visory Health, noted, "We're not just providing savings; we're providing peace of mind. We remain committed to breaking down barriers to healthcare for those who need it the most."

The implications of Visory Health's ranking extend beyond individual savings to broader industry and societal impacts. As prescription drug costs continue to strain household budgets and healthcare systems, platforms like Visory Health offer a viable alternative for uninsured or underinsured individuals, potentially reducing medication non-adherence due to cost. This can lead to improved health outcomes and decreased long-term healthcare expenses. The company's awards, including recognition from Inc. Best in Business, Modern Healthcare's Best in Business, Fast Company's Brands That Matter, and Digital Health Awards, validate its innovative approach to healthcare accessibility.

Looking forward, Visory Health's expansion efforts aim to further its core mission of ensuring affordable prescription access as a right rather than a privilege. In an era where healthcare affordability remains a pressing issue, the platform's success signals a shift toward patient-centric solutions that prioritize financial relief and accessibility. This news matters because it represents a tangible step toward alleviating the medication affordability crisis, offering hope and practical support to vulnerable populations across the nation.

Curated from Noticias Newswire

blockchain registration record for this content
FisherVista

FisherVista

@fishervista